Castleview Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,279
Closed -$34.5K 295
2024
Q4
$34.5K Sell
19,279
-1,547
-7% -$2.77K 0.02% 399
2024
Q3
$72.9K Buy
+20,826
New +$72.9K 0.04% 274